References
- AnsellJHirshJHylekEJacobsonACrowtherMPalaretiGPharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines8th edChest2008133Suppl 6160S198S18574265
- JamesAHBrittRPRaskinoCLThompsonSGFactors affecting the maintenance dose of warfarinJ Clin Pathol19924587047061401182
- WhitePPatient factors that influence warfarin dose responseJ Pharm Pract201023319420421507814
- HambergAKWadeliusMLindhJDA pharmacometric model describing the relationship between warfarin dose and INR response with respect to variations in CYP 2C9, VKORC1, and ageClin Pharmacol Ther201087672773420410877
- LacyCFArmstrongLLGoldmanMPLanceLLDrug Information Handbook17th edHudsonLexi-Comp Inc2008
- SinglaDLMorrillGBWarfarin maintenance dosages in the very elderlyAm J Health Syst Pharm200562101062106615901591
- AbsherRKMooreMEParkerMHPatient-specific factors predictive of warfarin dosage requirementsAnn Pharmacother200236101512151712243598
- WhitleyHPFermoJDChumneyECBrzezinskiWAEffect of patient-specific factors on weekly warfarin doseTher Clin Risk Manag20073349950418488070
- GageBFEbyCMilliganPEBanetGADuncanJRMcLeodHLUse of pharmacogenetics and clinical factors to predict the maintenance dose of warfarinThromb Haemost2004911879414691573
- GanGGTehAGohKYChongHTPangKWRacial background is a determinant factor in the maintenance dosage of warfarinInt J Hematol2003781848612894858
- GurwitzJHAvornJRoss-DegnanDChoodnovskiyIAnsellJAging and the anticoagulant response to warfarin therapyAnn Intern Med1992116119019041580446
- MerliGJPrevention of thrombosis with warfarin, aspirin, and mechanical methodsClin Cornerstone200574495616758652
- GarciaDReganSCrowtherMHughesRAHylekEMWarfarin maintenance dosing patterns in clinical practice: implications for safer anticoagulation in the elderly populationChest200512762049205615947319
- CrooksJO’MalleyKStevensonIHPharmacokinetics in the elderlyClin Pharmacokinet197614280296797500
- ShepherdAMHewickDSMorelandTAStevensonIHAge as a determinant of sensitivity to warfarinBr J Clin Pharmacol197743315320901699
- WoodhouseKWJamesOFHepatic drug metabolism and ageingBr Med Bull199046122352405943
- SchmuckerDLAging and the liver: an updateJ Gerontol A Biol Sci Med Sci1998535B315B3209754128
- Le CouteurDGMcLeanAJThe aging liver. Drug clearance and oxygen diffusion barrier hypothesisClin Pharmacokinet19983453593739592620
- LoguercioCTarantoDVitaleLMBeneduceFDel Vecchio BlancoCEffect of liver cirrhosis and age on the glutathione concentration in the plasma, erythrocytes, and gastric mucosa of manFree Radic Biol Med19962034834888720922
- SotaniemiEAArrantoAJPelkonenOPasanenMAge and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditionsClin Pharmacol Ther19976133313399091249
- CasnerPRSandovalEIncreased sensitivity to warfarin in elderly HispanicsJ Clin Pharmacol200242214515011831536
- BorgianiPCiccacciCForteVRomanoSFedericiGNovelliGAllelic variants in the CYP2V9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in ItaliansPharmacogenomics20078111545155018034619
- ChoHJSohnKHParkHMFactors affecting the interindividual variability of warfarin dose requirements in adult Korean patientsPharmacogenomics20078432933717391071
- YooSHNahHWJoMWAge and body weight adjusted warfarin initiation program for ischaemic stroke patientsEur J Neurol200916101100110519614967